Work

Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e20606

Authors: Ryan D. Gentzler, Richard Piekarz, Liza C Villaruz, John C. Rhee, Wei-Chu Victoria Lai, Bethany Horton, Joseph Mock, Michael Hanley, Michelle A. Rudek, Mitch A. Phelps, Michael Anthony Carducci, Charles M. Rudin

Institutions: University of Virginia Cancer Center, National Cancer Institute, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Memorial Sloan Kettering Cancer Center, University of Virginia, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The Ohio State University, Johns Hopkins Medicine

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4286294097

Cites:

Cited by: 1

Related to: 10